| 4 |
| JOHNSON & JOHNSON |
| 2.0M |
| $32.4M |
| 0.0% |
| 5.294% |
| 4.06% |
| 5 | FRANKLIN TEMPLETON INC | 1.8M | $30.1M | 0.0% | 4.920% | 0.01% |
| 6 | BALYASNY ASSET MANAGEMENT L.P. | 1.5M | $25.0M | -9.7% | 4.073% | 0.03% |
| 7 | VANGUARD CAPITAL MANAGEMENT LLC | 1.3M | $21.7M | +8.8% | 3.534% | 0.00% |
| 8 | PERCEPTIVE ADVISORS LLC | 1.3M | $20.6M | 0.0% | 3.358% | 0.31% |
| 9 | FMR LLC | 1.0M | $17.0M | +27.6% | 2.782% | 0.00% |
| 10 | MILLENNIUM MANAGEMENT LLC | 932K | $15.3M | -39.3% | 2.492% | 0.01% |
| 11 | GREAT POINT PARTNERS LLC | 921K | $15.1M | +15.2% | 2.465% | 2.85% |
| 12 | Longaeva Partners L.P. | 813K | $13.3M | +11.0% | 2.174% | 0.29% |
| 13 | Ikarian Capital, LLC | 808K | $13.2M | 0.0% | 2.161% | 1.43% |
| 14 | SECTORAL ASSET MANAGEMENT INC | 728K | $11.9M | 0.0% | 1.946% | 8.32% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 693K | $11.4M | +145.8% | 1.854% | 0.00% |
| 16 | HHLR ADVISORS, LTD. | 669K | $11.0M | 0.0% | 1.790% | 1.32% |
| 17 | Red Tree Management, LLC | 638K | $10.5M | 0.0% | 1.707% | 7.10% |
| 18 | Versant Venture Management, LLC | 543K | $8.9M | 0.0% | 1.451% | 5.47% |
| 19 | GOLDMAN SACHS GROUP INC | 497K | $8.2M | +61.9% | 1.330% | 0.00% |
| 20 | Boxer Capital Management, LLC | 494K | $8.1M | 0.0% | 1.321% | 0.61% |
| 21 | STATE STREET CORP | 426K | $7.0M | +320.5% | 1.139% | 0.00% |
| 22 | CITADEL ADVISORS LLC | 396K | $6.5M | +13.2% | 1.060% | 0.00% |
| 23 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 328K | $5.4M | — | 0.877% | 0.01% |
| 24 | SILVERARC CAPITAL MANAGEMENT, LLC | 296K | $4.9M | -1.8% | 0.792% | 0.50% |
| 25 | ADAR1 Capital Management, LLC | 279K | $4.6M | +0.8% | 0.746% | 0.21% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). “% of Fund” shows how much of that investor’s total 13F portfolio is invested in CTNM — a direct measure of their conviction.
| 58.59% |
| 2.59 pp |
| $105M |
| 54% |
| Q4 2024 | 62 | +19% | 61.18% | +8.23 pp | $231M | 9.8% |
| Q3 2024 | 52 | — | 52.95% | — | $256M | — |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Δ columns compare to the immediately prior filed quarter.
28 institutions opened new positions in CTNM during Q2 2026, while 14 fully exited. 62 added to existing positions and 11 trimmed.
CTNM institutional ownership fell by 0.30 percentage points quarter-over-quarter, with a net change of +12 holders.
The top 10 institutions account for 57.4% of all reported 13F value in CTNM, and the top 25 account for 85.4%.
Across the largest Immunology Biotech peers, institutional ownership levels are: LKFT (49.6%), YARW (1.2%), RKTO (7.9%). See the peer comparison table on this page for net buyer activity by company.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.